C-reactive protein in systemic lupus erythematosus

Autoimmunity

Volumn 42, Issue 4, 2009, Pages 282-285

  Batuca, J ^a   Delgado Alves, J ^a,b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b HOSPITAL CURRY CABRAL   (Portugal)

Author keywords

CRP; SLE; Vascular disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL NUCLEUS ANTIGEN; FC RECEPTOR;

APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BACTERIAL INFECTION; CELL ACTIVITY; COMPLEMENT CLASSICAL PATHWAY; DEFENSE MECHANISM; DISEASE ACTIVITY; DISEASE COURSE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; NONHUMAN; PATHOGENESIS; POPULATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RISK; RISK FACTOR; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ANIMALS; C-REACTIVE PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 70749150406     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902828130     Document Type: Short Survey

References (21)

1. Volanakis JE. Human CRP: Expression, structure, and function. Mol Immunol 2001;38:189-197.
2. Tillett WS, Francis Jr., T. Serological reactions in pneumonia with a non-protein fraction of pneumococcus. J Exp Med 1930;52:561-571.
3. Shrive AK, Cheetham GM, Holden D, Myles DA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC,Greenhough TJ. Three dimensional structure of human CRP. Nat Struct Biol 1996;3:346-354.
4. Bang R, Marnell L, Mold C, Chivington-Buck C, Du Clos KT, Du Clos TW. Analysis of binding sites in human CRP for FcgRI, FcgRIIa and C1q by site-mediated mutagenesis. J Biol Chem 2005;280:25095-25102.
5. Marnell L, Mold C, Du Clos TW. CRP: Ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-111.
6. Du Clos TW, Zlock LT, Rubin RL. Analysis of the binding of CRP to histones and chromatin. J Immunol 1988;141: 4266-4270.
7. Jewell WS, Marnell LL, Rokeach LA, Du Clos TW. CRP binding to the Sm-D protein of snRNPs. Identification of a short polypeptide binding region. Mol Immunol 1993;30:701-708.
8. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by CRP. Immunopharmacology 1999;42:23-30.
9. Mold C, Rodic-Polic B, Du Clos TW. Protection from Streptococcus pneumoniae infection by CRP and natural antibody requires complement but not Fcg receptors. J Immunol 2002;168:6375-6381.
10. Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW. CRP mediates protection from lipopolysaccharide through interactions with FcgR. J Immunol 2002;169:7019-7025.
11. Gershov D, Kim S, Brot N, Elkon KB. CRP binds to apo cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: Implications for systemic autoimmunity. J Exp Med 2000;192:1353-1363.
12. Abou-Raya A, Abou-Raya S. Inflammation: A pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 2006;5:331-337.
13. Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG. CRP levels during disease exacerbation and infections in SLE: A prospective longitudinal study. J Rheumatol 1990;17:1642-1648.
14. Vogt B, Führnrohr B, Müller R, Sheriff A. CRP and the disposal of dying cells: Consequences for SLE and rheumatoid arthritis. Autoimmunity 2007;40:295-298.
15. Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Marion TN, Volanakis JE. Delayed lupus onset in (NZB £ NZW)F1 mice expressing a human CRP transgene. Arthritis Rheum 2003;48:1602-1611.
16. Edberg JC, Wu J, Langefeld CD, Brown EE, Marion MC, McGwin Jr., G, Petri M, Ramsey-Goldman R, Reveille JD, Frank SG, Kaufman KM, Harley JB, Alarcón GS, Kimberly RP. Genetic variation in the CRP promoter: Association with SLE. Hum Mol Genet 2008;17:1147-1155.
17. Figueiredo MA, Rodriguez A, Ruiz-Yague M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R. AAb against CRP: Clinical associations in SLE and primary antiphospholipid syndrome. J Rheumatol 2006;33:1980-1986.
18. Lee S-S, Singh S, Magder LS, Petri M. Predictors of high sensitive CRP levels in patients with SLE. Lupus 2008;17: 114-123.
19. Lee S-S, Singh S, Link K, Petri M. High-sensitivity CRP as an associate of clinical and organ damage in SLE. Semin Arthritis Rheum 2008; in press.
20. Barnes EV, Narain S, Naranjo A, Shuster J, Segal MS, Sobel ES, Armstrong AE, Santiago BE, Reeves WH, Richards HB. High sensitivity CRP in SLE: Relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 2005;14:576-582.
21. Ames PRJ, Antinolfi I, Ciampa A, Batuca J, Scenna G, Lopez LR, Delgado Alves J, Iannaccone L, Matsuura E. Primary antiphospholipid syndrome. A low grade autoinflammatory disease? Rheumatology (Oxford) 2008;47: 1832-1837.